Original research
par
Dunlop, Adrian J. et al
Date de publication
2022
Géographie
Australia
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Oui
Évalué par des pairs
Yes
L’objectif
This study assessed the safety of subcutaneous slow-release depot buprenorphine in custody.
Constatations/points à retenir
This first study of depot buprenorphine in custodial settings showed treatment retention and outcomes comparable to those observed in community settings and for other opioid agonist treatment used in custodial settings, without increased risk of diversion.
La conception ou méthodologie de recherche
Open-label, non-randomized trial.
Mots clés
Outcomes
Legal system/law enforcement
Substitution/OAT
Diversion